Clinical trial
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
NCT00455143 · Icahn School of Medicine at Mount Sinai, Other · Terminated
Key facts
| NCT number | NCT00455143 |
|---|---|
| Title | Cognitive Protection - Dexmedetomidine and Cognitive Reserve |
| Official title | Cognitive Protection - Dexmedetomidine and Cognitive Reserve |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Postoperative Delirium, PD, Postoperative Cognitive Dysfunction, POCD |
| Intervention type | Drug |
| Interventions | Precedex (Dexmedetomidine), Placebo |
| Enrollment | 27 |
| Start date | Sep 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Apr 3, 2007 |
| Last update posted | Jul 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: